It has been a mixed year for Sight Sciences, Inc. insiders: $185,000 bought by one person and $2.9 million sold by six, so more selling than buying overall.
Biggest single buyer: Encrantz Staffan, Director, with roughly $116,000.
5 quarters in a row of net selling by insiders. Insiders bought in 4 of the last 7 full quarters. 112 investment managers listed SGHT in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Taylor Brenton | Executive Officer | Sell | 2,988 | $8.85 | $26K | SEC |
| Oct 5, 2026 | Rodberg James | CFO | Sell | 7,208 | $8.85 | $64K | SEC |
| Oct 5, 2026 | Badawi David | Executive Officer | Sell | 7,797 | $9.05 | $71K | SEC |
| Oct 5, 2026 | Badawi Paul | CEO | Sell | 29,653 | $9.05 | $268K | SEC |
| Oct 5, 2026 | Bauerlein Alison | COO | Sell | 25,260 | $8.85 | $224K | SEC |
| Jul 6, 2026 | HAYDEN JEREMY B. | Executive Officer | Sell | 12,733 | $5.51 | $70K | SEC |
| Jul 6, 2026 | Rodberg James | CFO | Sell | 6,902 | $5.36 | $37K | SEC |
| Jul 6, 2026 | Badawi David | Executive Officer | Sell | 7,418 | $5.51 | $41K | SEC |
| Jul 6, 2026 | Taylor Brenton | Executive Officer | Sell | 2,829 | $5.42 | $15K | SEC |
| Jul 6, 2026 | Bauerlein Alison | COO | Sell | 24,184 | $5.36 | $130K | SEC |
| Jul 6, 2026 | Badawi Paul | CEO | Sell | 28,684 | $5.42 | $155K | SEC |
| Jun 11, 2026 | Encrantz Staffan | Director | Buy | 14,100 | $4.88 | $69K | SEC |
| May 19, 2026 | Bauerlein Alison | COO | Sell | 12,728 | $5.12 | $65K | SEC |
| Apr 9, 2026 | Rodberg James | CFO | Sell | 7,231 | $3.55 | $26K | SEC |
| Apr 9, 2026 | HAYDEN JEREMY B. | Executive Officer | Sell | 13,761 | $3.55 | $49K | SEC |
In the last 12 months Sight Sciences, Inc. insiders made open-market purchases worth about $185,000 and sales worth about $2.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SGHT was filed on 2026-10-05.
112 investment managers reported holding SGHT in SEC Form 13F filings for Q2 2026.
No congressional trades in SGHT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).